
Share on:
Orthopedic OEMs have remained active in terms of M&A and new product development, despite disruptions from COVID-19. Our latest infographic provides a look at orthopedics from a range of viewpoints—sales by geographic region, recent large acquisitions and a breakdown of FDA 510(k) clearances by market segments and companies.
Infographic sponsored by Orchid Orthopedic Solutions
RELATED ARTICLES
Kapstone Manufacturing to Integrate In-House DLyte Dry Electropolishing
Jun 04 2026 , Julie A. Vetalice
5 Packaging Validation Mistakes That Delay FDA Clearance
Jun 01 2026 , Matthew Emerick
Small Joint Implants: A New Era with Medureon™ Bionate™
Jun 01 2026 , dsm -firmenich




